Cartesian Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $34.9M | $34.1M | $815.0K | $5.4M |
| FY2021 | $-60.4M | $-61.5M | $1.1M | $7.7M |
| FY2022 | $-31.6M | $-32.8M | $1.2M | $11.2M |
| FY2023 | $-51.2M | $-51.4M | $206.0K | $22.5M |
| FY2024 | $-23.7M | $-32.8M | $9.1M | $6.6M |